We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVA
251
DELISTED
NuVasive, Inc.
NUVA
| $11.1M | 0.09% |
197,819
-13,065
| -6% | -$643K |
|
252
DexCom
DXCM
$34.5B
| $11.1M | 0.09% |
+120,140
| New | +$10.7M |
|
253
BioNTech
BNTX
$23.1B
| $11.1M | 0.09% |
+135,947
| New | +$13.3M |
|
254
West Pharmaceutical
WST
$24.4B
| $11M | 0.09% |
38,766
+37,841
| +4,091% | +$10.6M |
|
255
Waters Corp
WAT
$40.6B
| $11M | 0.09% |
44,355
-36,548
| -45% | -$8.28M |
|
256
Boston Beer
SAM
$1.9B
| $11M | 0.09% |
11,016
-9,541
| -46% | -$9.16M |
|
257
Motorola Solutions
MSI
$77B
| $10.9M | 0.09% |
+63,951
| New | +$10.7M |
|
|
LAC
258
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $10.8M | 0.09% |
860,195
+606,309
| +239% | +$6.82M |
|
259
D.R. Horton
DHI
$41.9B
| $10.7M | 0.09% |
+155,717
| New | +$11.4M |
|
260
Carlisle Companies
CSL
$14.9B
| $10.7M | 0.09% |
68,373
-597
| -0.9% | -$83.9K |
|
261
Kohl's
KSS
$2.22B
| $10.6M | 0.09% |
260,670
-1,182,047
| -82% | -$34.4M |
|
262
Graphic Packaging
GPK
$3.51B
| $10.5M | 0.09% |
617,330
+517,707
| +520% | +$7.83M |
|
263
Celsius Holdings
CELH
$7.28B
| $10.4M | 0.09% |
620,148
+221,913
| +56% | +$2.22M |
|
|
AZUL
264
DELISTED
Azul
AZUL
| $10.4M | 0.09% |
454,507
-71,482
| -14% | -$1.28M |
|
|
SWAV
265
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $10.2M | 0.09% |
98,139
+17,610
| +22% | +$1.53M |
|
266
BCE
BCE
$21.7B
| $10.2M | 0.09% |
237,374
-87,531
| -27% | -$3.74M |
|
267
EPR Properties
EPR
$4.73B
| $10.1M | 0.09% |
311,636
-49,870
| -14% | -$1.47M |
|
268
LivePerson
LPSN
$35.9M
| $10.1M | 0.08% |
10,834
+10,102
| +1,380% | +$8.69M |
|
269
Chemed
CHE
$7.02B
| $10.1M | 0.08% |
18,870
+11,010
| +140% | +$5.41M |
|
|
CLR
270
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $10M | 0.08% |
616,321
+213,986
| +53% | +$3.2M |
|
271
American Eagle Outfitters
AEO
$2.73B
| $10M | 0.08% |
499,903
+83,273
| +20% | +$1.4M |
|
272
Tesla
TSLA
$1.34T
| $9.98M | 0.08% |
+42,438
| New | +$7.24M |
|
|
INFO
273
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $9.94M | 0.08% |
110,694
-175,629
| -61% | -$15.2M |
|
274
Groupon
GRPN
$894M
| $9.94M | 0.08% |
261,483
-182,974
| -41% | -$5.03M |
|
275
SLB Ltd
SLB
$77.3B
| $9.91M | 0.08% |
+454,143
| New | +$8.57M |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.